HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.

Abstract
Hypertrophy allows the heart to adapt to workload but culminates in later pump failure; how it is achieved remains uncertain. Previously, we showed that hypertrophy is accompanied by activation of cyclin T/Cdk9, which phosphorylates the C-terminal domain of the large subunit of RNA polymerase II, stimulating transcription elongation and pre-mRNA processing; Cdk9 activity was required for hypertrophy in culture, whereas heart-specific activation of Cdk9 by cyclin T1 provoked hypertrophy in mice. Here, we report that alphaMHC-cyclin T1 mice appear normal at baseline yet suffer fulminant apoptotic cardiomyopathy when challenged by mechanical stress or signaling by the G-protein Gq. At pathophysiological levels, Cdk9 activity suppresses many genes for mitochondrial proteins including master regulators of mitochondrial function (peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1), nuclear respiratory factor-1). In culture, cyclin T1/Cdk9 suppresses PGC-1, decreases mitochondrial membrane potential, and sensitizes cardiomyocytes to apoptosis, effects rescued by exogenous PGC-1. Cyclin T1/Cdk9 inhibits PGC-1 promoter activity and preinitiation complex assembly. Thus, chronic activation of Cdk9 causes not only cardiomyocyte enlargement but also defective mitochondrial function, via diminished PGC-1 transcription, and a resulting susceptibility to apoptotic cardiomyopathy.
AuthorsMotoaki Sano, Sam C Wang, Manabu Shirai, Fernando Scaglia, Min Xie, Satoshi Sakai, Toru Tanaka, Prathit A Kulkarni, Philip M Barger, Keith A Youker, George E Taffet, Yasuo Hamamori, Lloyd H Michael, William J Craigen, Michael D Schneider
JournalThe EMBO journal (EMBO J) Vol. 23 Issue 17 Pg. 3559-69 (Sep 01 2004) ISSN: 0261-4189 [Print] England
PMID15297879 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CCNT1 protein, human
  • Ccnt1 protein, mouse
  • Ccnt1 protein, rat
  • Cyclin T
  • Cyclins
  • DNA-Binding Proteins
  • NF-E2-Related Factor 1
  • NRF1 protein, human
  • Nfe2l1 protein, rat
  • Nrf1 protein, mouse
  • Nuclear Respiratory Factor 1
  • Nuclear Respiratory Factors
  • Trans-Activators
  • Transcription Factors
  • peroxisome-proliferator-activated receptor-gamma coactivator-1
  • Cdk9 protein, mouse
  • Cyclin-Dependent Kinase 9
  • RNA Polymerase II
Topics
  • Animals
  • Apoptosis
  • Cells, Cultured
  • Cyclin T
  • Cyclin-Dependent Kinase 9 (metabolism)
  • Cyclins (metabolism)
  • DNA-Binding Proteins (genetics, metabolism)
  • Enzyme Activation
  • Gene Expression
  • Heart Failure (etiology, genetics, metabolism)
  • Humans
  • Mice
  • Myocardium (metabolism)
  • Myocytes, Cardiac (metabolism, pathology)
  • NF-E2-Related Factor 1
  • Nuclear Respiratory Factor 1
  • Nuclear Respiratory Factors
  • Promoter Regions, Genetic
  • RNA Polymerase II (metabolism)
  • Rats
  • Trans-Activators (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: